ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Bio-Rad Laboratories Inc. Cl A (BIO) Report Updated: Jun 17, 2013 | Print This Page

Get more stock ratings by Louis Navellier

Bio-Rad Laboratories Inc. Cl A (BIO)

Rating: Sell Volatility: Conservative
Total Grade: D Industry: Life Sciences Tools & Services
Competitors: AMRI, PRXL, WX, ICLR

Stock Analysis

Rating: Monthly View

A
B
C
D
F
June July August September October November December January February March April May

Rating: Weekly View

This Week: D down downgrade
Last Week: C same no change
Two Weeks Ago: C up upgrade
service keys

Bio-Rad Laboratories Inc. Cl A© quotemedia

Company Profile

Bio-Rad Laboratories, Inc. engages in the manufacture and distribution of life science research and clinical diagnostic products worldwide. The company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. This segment serves various customers, including universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for the healthcare market. This segment sells its products to reference laboratories, hospital laboratories, screening facilities, physicians’ office laboratories, transfusion laboratories, and insurance and forensic testing laboratories. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.